Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...

"These drugs have the potential to change societies, not just individuals." — Michael Le Page, New Scientist, March 29, 2025 ...

The Mounjaro (tirzepatide) product information warns that inflammation of the pancreas (acute pancreatitis) is an uncommon ...

Weight loss drugs Mounjaro and Wegovy, as well as diabetes jab Ozempic may be linked to life-threatening health problems ...

The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...

Data show that since the drugs were licensed there have been hundreds of cases of acute and chronic pancreatitis ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...